For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...

In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those without HIV.

Lots of scholarship assumes that partners in higher-quality relationships work together to reduce health-related risks. A new study tested this assumption.

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...